Advertisement

International Ophthalmology

, Volume 34, Issue 6, pp 1263–1265 | Cite as

Good visual outcome of tuberculous chorioretinitis after ART initiation in a HIV-infected patient

  • Erik SchaftenaarEmail author
  • Christina Meenken
  • G. Seerp Baarsma
  • Georges M. G. M. Verjans
  • Remco P. H. Peters
Photo Essay

Abstract

Mycobacterium tuberculosis infection is an important cause of sight-threatening chorioretinitis in HIV-infected individuals living in M. tuberculosis endemic areas. We present a case of tuberculous chorioretinitis in a HIV-infected man after recent initiation of antiretroviral therapy in rural South Africa, who had nearly complete resolution of clinical signs and symptoms after standard tuberculosis treatment. His presentation was most likely associated with immune reconstitution inflammatory syndrome.

Keywords

Mycobacterium tuberculosis Tuberculous chorioretinitis HIV Immune reconstitution inflammatory syndrome South Africa 

Notes

Acknowledgments

This study was in part funded by the “Rotterdamse Stichting Blindenbelangen” and the “Rotterdam Global Health Initiative”. We thank Gerard de Graaf and Fabienne Wink from the Rotterdam Eye Hospital (Rotterdam, The Netherlands) for refining the pictures included in this manuscript.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standards

This study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. The person described in this study gave informed consent for publication of this study. Details that might disclose the identity of the subject under study have been omitted.

References

  1. 1.
    Schaftenaar E, van Gorp ECM, Meenken C et al (2014) Ocular infections in sub-Saharan Africa in the context of high HIV prevalence. Trop Med Int Health. doi: 10.1111/tmi.12350 PubMedGoogle Scholar
  2. 2.
    Basu S, Monira S, Modi RR et al (2014) Degree, duration, and causes of visual impairment in eyes affected with ocular tuberculosis. J Ophthalmic Inflamm Infect 4:3. doi: 10.1186/1869-5760-4-3 PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Thompson MJ, Albert DM (2005) Ocular tuberculosis. Arch Ophthalmol 123:844–849PubMedCrossRefGoogle Scholar
  4. 4.
    Otiti-Sengeri J, Meenken C, van den Horn GJ, Kempen JH (2008) Ocular immune reconstitution inflammatory syndromes. Curr Opin HIV AIDS 3:432–437. doi: 10.1097/COH.0b013e328302cc3d PubMedCrossRefGoogle Scholar
  5. 5.
    Lawn SD, Myer L, Bekker LG, Wood R (2007) Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 21:335–341PubMedCrossRefGoogle Scholar
  6. 6.
    Abu El-Asrar AM, Al-Mezaine HS (2010) Anti-tuberculous therapy combined with systemic corticosteroids improves retinal sensitivity in patients with active presumed tuberculous choroiditis. Int Ophthalmol 30:567–576. doi: 10.1007/s10792-010-9371-2 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  • Erik Schaftenaar
    • 1
    • 2
    • 3
    Email author
  • Christina Meenken
    • 4
  • G. Seerp Baarsma
    • 1
  • Georges M. G. M. Verjans
    • 2
  • Remco P. H. Peters
    • 3
  1. 1.Rotterdam Eye HospitalRotterdamThe Netherlands
  2. 2.Department of ViroscienceErasmus MCRotterdamThe Netherlands
  3. 3.Anova Health InstituteJohannesburg and TzaneenSouth Africa
  4. 4.Department of OphthalmologyVU University Medical CenterAmsterdamThe Netherlands

Personalised recommendations